Steve Yip, MD, MSc

681 posts

Steve Yip, MD, MSc banner
Steve Yip, MD, MSc

Steve Yip, MD, MSc

@Yipilimumab

Medical Oncologist, POET Medical Lead, Chair Southern Alberta GU Tumour Group, Clinical Associate Professor, Tom Baker Cancer Centre. Opinions are my own.

Calgary, Alberta Katılım Aralık 2016
497 Takip Edilen490 Takipçiler
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Proud to have participated in the biomarker driven CAPITELLO trial, presented by Dr. Fizazi, showing significant rPFS benefit with capi + abi vs pbo + abi in PTEN deficient mCSPC. Another biomarker challenge is on the horizon as elegantly highlighted by @Ecastromarcos #ESMO25
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
1
63
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Impressive results from EMBARK demonstrating Enza combo reduced risk of death by > 40% vs ADT alone in patients with high risk #ProstateCancer #ESMO25
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
0
62
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
An impactful trial PR.21 led by Dr. Kim Chi demonstrating no difference in rPFS between 177Lu-PSMA vs docetaxel in PSMA PET positive mCRPC. Proud to have contributed to this important Canadian #ProstateCancer trial at #esmo2025 #pluvicto #ESMO25
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
1
71
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Great talk from Prof. Dr Bono on ctDNA as a biomarker in lutetium PSMA in exploratory analysis from PSMAfore. Hi ctDNA associated with poor rPFS/OS, and ctDNA clearance associated with improved rPFS/OS
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
0
104
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Amazing work from the TALAPRO2 team @neerajaiims with an amazing all comer OS benefit with tala + enza in mCRPC and detailed genomics analysis, particularly BRCAm @fizazi_karim We’re truly privileged to have contributed to this pivotal study!
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
1
101
Arun Azad
Arun Azad@AzadOncology·
Leaving #ESMO24 after a fantastic meeting. 🙏 @myESMO for the honour of being Prostate Track Chair (passing the baton to @dmukherji in 2025) & the chance to present UpFrontPSMA trial. Many great advances for #ProstateCancer pts & happy times with friends. I ❤️ Barcelona
Arun Azad tweet mediaArun Azad tweet media
English
2
9
55
3.5K
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Immunotherapy has its role in a select few #ProstateCancer pts with MMRd with impressive outcomes on Nivo/Ipi as presented by Dr. Mehra. We’re working to identify and characterize these pts, and we need to do better #ESMO24
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
0
2
107
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Excellent talk by Dr. Saad on a new mCSPC #prostatecancer treatment option with darolutamide plus ADT with a significant rPFS benefit over ADT. This will allow our patients, who have borderline candidacy for chemo, to gain access to darolutamide in this setting #ESMO2024
Steve Yip, MD, MSc tweet mediaSteve Yip, MD, MSc tweet media
English
0
2
5
266
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Thank you @UCalgaryMed I am proud to work with amazing colleagues and friends at the TBCC and soon to be Arthur JE Child Cancer Centre @weowncancer @AHS_CancerCare @AHS_media @UCalgary
UCalgaryMedicine@UCalgaryMed

📣Bravo to some of @AvenueMagazine’s Top 40 under 40 recipients from #UCalgaryMed, Drs. Husein Moloo, MD'13, PGME'15, Steven Yip, MD, PGME'17 and Julie Deleemans, PhD'22! Read more about their compassionate and visionary work, linked below. @jmdeleem87 @Yipilimumab @Charb_Cancer

English
1
0
7
564
Steve Yip, MD, MSc
Steve Yip, MD, MSc@Yipilimumab·
Thanks so much Christy! I can’t thank you and @albertacancer enough for your nomination. I’m always here for you and @weowncancer Together, we’re achieving amazing things in cancer care for our patients.
Christy Holtby@christyholtby

@Yipilimumab @AvenueMagazine @DrDanielHeng @AHS_media @albertacancer @AHS_CancerCare @weowncancer Congratulations Steve! Completely deserved. And thank you for all you do in support of @albertacancer and @weowncancer (and making it fun!)

English
0
0
3
334

Keşfet

@Ecastromarcos @DrDanielHeng @CancerWorldmag @Nimira_A @POETOncology @neerajaiims @fizazi_karim @AzadOncology